myLaminin Perspectives

Secure research collaboration is critical for universities, hospitals, CROs, biotech, and pharmaceutical organizations across Canada and the United States. As clinical trial data, IP, and regulatory information are shared, trust is the foundation. This article explores why secure research collaboration platforms matter and how myLaminin enables SOC 2 Type II compliant, patented collaboration across North America while protecting sensitive research data and accelerating discov

Five years ago, myLaminin began with a single idea. Today, it has evolved into a connected research ecosystem supporting the complete research lifecycle—from grant submission through publication. Discover how one conversation with a Canadian U15 university transformed our vision, how researchers co-designed our platform, and how myLaminin became a sovereign Research Data Management (RDM) and Clinical Trial Management System (CTMS) built for active science.

The new ICH E6(R3) guidelines are transforming clinical research worldwide, requiring Quality-by-Design, risk-based oversight, and validated digital systems. Discover how myLaminin's co-designed Clinical Trial Operations (CTOps) and CTMS platform helps research teams, principal investigators, administrators, and compliance professionals streamline operations, strengthen data integrity, improve audit readiness, and meet evolving global regulatory requirements with confidence.

Learn the differences between CTMS, EDC, and eTMF and how these essential clinical trial systems work together to improve research operations, data quality, regulatory compliance, and study efficiency. This guide explains the role of each platform, their integration across the clinical trial lifecycle, and how myLaminin's Research Data Management platform combines CTMS capabilities, participant management, eTMF, protocol management, audit trails, and 21 CFR Part 11 compliant

Discover how Clinical Trial Management Systems (CTMS) help academic research institutions improve compliance, reduce administrative burden, accelerate study start-up, and support ICH E6(R3)-aligned clinical trial operations.

earn how sponsors can manage protocol deviations, amendments, eTMF documentation, and regulatory compliance in multi-site clinical trials under evolving ICH E6(R3) expectations.

Clinical trial start-up delays continue to impact site activation, budgets, and timelines due to fragmented workflows across feasibility, contracting, IRB/REB approvals, training, and system readiness. This article explains how CTMS platforms, integrated research systems, and AI-driven automation reduce inefficiencies by centralizing processes, improving visibility, and accelerating trial activation across global clinical research environments.

Learn how ICH E6 (R3) is reshaping clinical trials through risk-based quality management, decentralized research oversight, data integrity, and continuous inspection readiness across global clinical research operations.

ICH E6 (R3) is reshaping clinical trial compliance across Canada, the U.S., EU, UK, and Australia. The updated Good Clinical Practice (GCP) guideline emphasizes Quality by Design, proactive risk management, audit trail traceability, sponsor oversight, informed consent, data integrity, and inspection readiness. myLaminin helps research teams and sponsors manage multi-site clinical trials with real-time oversight, CTQ monitoring, compliant eConsent, secure audit trails, and val

Multi-site clinical trials are widely used across North America to improve recruitment and accelerate timelines, but hidden operational risks often undermine success. Site variability, uneven engagement, communication breakdowns, and fragmented technology adoption create systemic inefficiencies that erode data quality and compliance. Without integrated oversight and standardized processes, complexity scales faster than control, increasing trial failure risk.

Poor clinical trial coordination drives costly delays, data integrity risks, and regulatory exposure across multi-site studies in Canada, the US, and globally. Fragmented systems, inconsistent documentation, and weak communication slow approvals, inflate Phase III costs, and erode patient trust. Integrated CTMS/CR/os platforms like myLaminin unify stakeholders, streamline workflows, strengthen compliance, and enable real-time oversight turning coordination into a competitive

Running clinical trials without a Clinical Trial Management System (CTMS) creates hidden operational burdens, from fragmented data and compliance risks to poor collaboration and reduced patient engagement. Disconnected tools like spreadsheets and email slow execution, increase errors, and threaten data integrity. A centralized CTMS streamlines workflows, ensures regulatory compliance, and improves trial efficiency, making it essential for scalable, secure, and successful clin

Spreadsheet-driven clinical trials introduce hidden risks in compliance, data integrity, and efficiency. While Excel remains a convenient tool, it often evolves into ungoverned infrastructure, creating version control issues, audit gaps, and costly delays. Modern CTMS platforms like myLaminin help research teams reduce spreadsheet dependency, strengthen governance, and streamline workflows without sacrificing flexibility in complex, data-intensive studies.

Digital twins are transforming personalized healthcare, but their impact depends on secure, interoperable data. myLaminin enables this with an integrated Research Data Management platform that unifies eConsent, CTMS, HL7 FHIR integration, and secure repositories. The result: compliant, AI-driven digital twin models that continuously learn, improve, and deliver more accurate clinical outcomes.

Modern clinical trials demand integrated systems to streamline workflows, centralize data, and ensure compliance. Fragmented tools slow research, increase costs, and risk errors, while platforms like myLaminin CTMS enhance efficiency, oversight, and data quality. By accelerating studies without compromising accuracy, modern clinical trial infrastructure supports faster, safer drug development and more reliable outcomes for patients.

University-led clinical trials are evolving as academic institutions adopt industry-grade infrastructure, centralized systems, and compliant data practices. Driven by growing complexity, AI, and digital health, universities are professionalizing research operations end-to-end. Platforms like myLaminin enable scalable, secure, and compliant trial execution bridging the gap between early discovery and full clinical development.

CROs have evolved into essential partners in clinical trials, offering scalability, expertise, and global reach amid rising complexity. However, fragmented systems, blurred oversight, and data silos create risk. The future lies in integrated platforms like myLaminin that connect sponsors, CROs, and sites, improving transparency, governance, and execution across decentralized research ecosystems.

Clinical research is falling behind healthcare IT due to fragmented systems, weak incentives, and lack of a true system of record. Many teams still rely on spreadsheets and disconnected tools, slowing studies and limiting collaboration. Strong clinical research data management, better governance, and connected platforms like myLaminin can help organizations improve efficiency, maintain context, and build scalable, future-ready research infrastructure.

Rising clinical trial costs are driven by growing protocol complexity, recruitment challenges, site capacity limits, regulatory burdens, and expanding data demands. These inefficiencies strain sponsors and delay outcomes. By adopting quality-by-design, optimizing protocols, improving patient engagement, and leveraging integrated CTMS and RDM platforms, organizations can reduce costs, enhance compliance, and accelerate clinical research while maintaining data integrity.

Global clinical trials are growing in scale and complexity as research expands across institutions and jurisdictions. Investigators must manage regulatory compliance, protect sensitive participant data, and maintain strong data governance. Effective clinical trial management systems are essential to support secure collaboration, protocol compliance, and reliable research outcomes.